Abo Bibliothek: Guest
Critical Reviews™ in Therapeutic Drug Carrier Systems

Erscheint 6 Ausgaben pro Jahr

ISSN Druckformat: 0743-4863

ISSN Online: 2162-660X

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.7 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 3.6 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.8 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00023 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.39 SJR: 0.42 SNIP: 0.89 CiteScore™:: 5.5 H-Index: 79

Indexed in

Long-Acting Injectables: Current Perspectives and Future Promise

Volumen 36, Ausgabe 2, 2019, pp. 137-181
DOI: 10.1615/CritRevTherDrugCarrierSyst.2018025649
Get accessGet access

ABSTRAKT

The parenteral route of administration is preferred over the oral route for treatment of many chronic and life-threatening diseases due to better patient compliance. Long-acting injectables/depot delivery systems are formulations intended for prolonged/sustained drug release over a long period of time ranging from a few days to months. Depot delivery systems enhance product quality by decreasing dosing frequency, simplifying the drug regimen. Parenteral depots reduce the relapse rate of disease and the maintenance phase of therapy, hence improving efficacy and treatment adherence. However, despite being extensively explored in the last seventy years, only a few depot products have been marketed or have reached commercial viability. The introduction of long-acting injectables of any drug took 9 to 10 years after approval of its oral formulation. Mainly the market has been conquered by long-acting injectables for antipsychotic, substance abuse, and hormonal therapy drugs.
This article focuses on the preparation of long-acting injectables with special emphasis on challenges associated with formulation. The evolution and current global market trend of various depot formulations are also discussed. Insight is provided into the promising future of long-acting injectables of protein-based drugs as well as multidrug therapy, along with potential uses in the treatment of chronic diseases like HIV, Parkinson's, and Alzheimer's.

REFERENZIERT VON
  1. Nkanga Christian Isalomboto, Fisch Andreas, Rad-Malekshahi Mazda, Romic Marieta Duvnjak, Kittel Birgit, Ullrich Thomas, Wang Jing, Krause Rui Werner Maçedo, Adler Sabine, Lammers Twan, Hennink Wim E., Ramazani Farshad, Clinically established biodegradable long acting injectables: An industry perspective, Advanced Drug Delivery Reviews, 167, 2020. Crossref

  2. Steiner Jonas, Alaneed Razan, Kressler Jörg, Mäder Karsten, Fatty acid-modified poly(glycerol adipate) microparticles for controlled drug delivery, Journal of Drug Delivery Science and Technology, 61, 2021. Crossref

  3. Gupta Harshita, Panchal Rutu, Acharya Niyati, Mehta Priti Jignesh, Controlled Parenteral Formulations: An Efficacious and Favourable Way to Deliver the Anti-psychotic Drugs, Current Psychiatry Research and Reviews, 16, 1, 2020. Crossref

  4. Karava Vasiliki, Siamidi Aggeliki, Vlachou Marilena, Christodoulou Evi, Bikiaris Nikolaos D., Zamboulis Alexandra, Kostoglou Margaritis, Gounari Eleni, Barmpalexis Panagiotis, Poly(l-Lactic Acid)-co-poly(Butylene Adipate) New Block Copolymers for the Preparation of Drug-Loaded Long Acting Injectable Microparticles, Pharmaceutics, 13, 7, 2021. Crossref

  5. ÖRÜM Mehmet Hamdi, Paliperidon Palmitat Aylık Uzun Etkili Enjeksiyon Kullanan Şizofreni ve Bipolar Bozukluk Tip 1 Tanılı Hastaların İncelenmesi, Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi, 2020. Crossref

  6. Yang Kai-Chun, Liao Yin-To, Yang Yen-Kuang, Lin Shih-Ku, Liang Chih-Sung, Bai Ya-Mei, Evidence-Based Expert Consensus Regarding Long-Acting Injectable Antipsychotics for Schizophrenia from the Taiwanese Society of Biological Psychiatry and Neuropsychopharmacology (TSBPN), CNS Drugs, 35, 8, 2021. Crossref

  7. Shadowen Caroline, Moeller Frederick Gerard, Martin Caitlin E., The Use of Once-monthly Injectable Buprenorphine for the Treatment of Opioid Use Disorder in Postpartum Women: A Case Series, Journal of Addiction Medicine, 15, 4, 2021. Crossref

  8. Du Liping, Liu Shankui, Hao Guizhou, Zhang Li, Zhou Miaomiao, Bao Yueqing, Ding Bing, Sun Qinyong, Zhang Guimin, Preparation and Release Profiles in Vitro/Vivo of Galantamine Pamoate Loaded Poly (Lactideco-Glycolide) (PLGA) Microspheres, Frontiers in Pharmacology, 11, 2021. Crossref

  9. Aguglia Andrea, Fusar-Poli Laura, Amerio Andrea, Placenti Valeria, Concerto Carmen, Martinotti Giovanni, Carrà Giuseppe, Bartoli Francesco, D'Agostino Armando, Serafini Gianluca, Amore Mario, Aguglia Eugenio, Ostuzzi Giovanni, Barbui Corrado, The Role of Attitudes Toward Medication and Treatment Adherence in the Clinical Response to LAIs: Findings From the STAR Network Depot Study, Frontiers in Psychiatry, 12, 2021. Crossref

  10. Larrañeta Eneko, Raghu Raj Singh Thakur, Donnelly Ryan F., Overview of the clinical current needs and potential applications for long-acting and implantable delivery systems, in Long-Acting Drug Delivery Systems, 2022. Crossref

  11. Rybchenko O. I., Suslov V. V., Kedik S. A., Domnina Yu. M., Mogaibo A. I., Flow Dispersion for Obtaining Ivermectin Encapsulated in Polycaprolactone Microparticles, Drug development & registration, 11, 2, 2022. Crossref

  12. Bock Frederik, Bøtker Johan Peter, Larsen Susan Weng, Lu Xujin, Østergaard Jesper, Methodological Considerations in Development of UV Imaging for Characterization of Intra-Tumoral Injectables Using cAMP as a Model Substance, International Journal of Molecular Sciences, 23, 7, 2022. Crossref

  13. Gou Jingxin, Wang Silin, Li Xu, Yin Tian, He Haibing, Zhang Yu, Tang Xing, Xiao Wei, Wang Zhenzhong, Reduced In vivo burst release of ginkgolide B microcrystals achieved by polymeric H+ depot, Journal of Drug Delivery Science and Technology, 67, 2022. Crossref

  14. K Yuvaneshwari, Kollipara Sivacharan, Ahmed Tausif, Chachad Siddharth, Applications of PBPK/PBBM modeling in generic product development: An industry perspective, Journal of Drug Delivery Science and Technology, 69, 2022. Crossref

  15. Shakil Anika, Hern Faye Y., Liu Chung, Temburnikar Kartik, Chambon Pierre, Liptrott Neill, McDonald Tom O., Neary Megan, Owen Andrew, Freel Meyers Caren, Rannard Steve P., Linear and branched polymer prodrugs of the water-soluble nucleoside reverse-transcriptase inhibitor emtricitabine as structural materials for long-acting implants, Journal of Materials Chemistry B, 10, 23, 2022. Crossref

  16. Wang Ze-Yu, Zhang Xu-Wei, Ding Yan-Wen, Ren Zi-Wei, Wei Dai-Xu, Natural biopolyester microspheres with diverse structures and surface topologies as micro-devices for biomedical applications, Smart Materials in Medicine, 4, 2023. Crossref

  17. Ibrahim Tarek M., Ayoub Margrit M., El-Bassossy Hany M., El-Nahas Hanan M., Gomaa Eman, Investigation of Alogliptin-Loaded In Situ Gel Implants by 23 Factorial Design with Glycemic Assessment in Rats, Pharmaceutics, 14, 9, 2022. Crossref

  18. Wilkinson Janine, Ajulo Damilola, Tamburrini Valeria, Gall Gwenaelle Le, Kimpe Kristof, Holm Rene, Belton Peter, Qi Sheng, Lipid based intramuscular long-acting injectables: Current state of the art, European Journal of Pharmaceutical Sciences, 178, 2022. Crossref

  19. Egelund Eric F, Huston Jessica, HIV Prevention Utilizing Long-acting Injectables, Infectious Diseases, 1, 1, 2022. Crossref

  20. Liang Di, Li Qi, Du Lina, Dou Guifang, Pharmacological Effects and Clinical Prospects of Cepharanthine, Molecules, 27, 24, 2022. Crossref

Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen Preise und Aborichtlinien Begell House Kontakt Language English 中文 Русский Português German French Spain